• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二聚化:保护戊型肝炎病毒衣壳蛋白免受胰蛋白酶作用的结构特征。

Dimerization: a structural feature for the protection of hepatitis E virus capsid protein against trypsinization.

机构信息

Department of Microbiology and Immunology, School of Medicine, Southeast University, Nanjing, Jiangsu province, China.

出版信息

Sci Rep. 2018 Jan 29;8(1):1738. doi: 10.1038/s41598-018-20137-2.

DOI:10.1038/s41598-018-20137-2
PMID:29379064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5788867/
Abstract

Orally-transmitted viruses have evolved in a way to resist the extreme conditions of the host's gastrointestinal environment, especially the proteolysis of their structural proteins. However, the mechanisms allowing these viruses to survive these harsh conditions remain unclear. Hepatitis E virus (HEV) is an orally-transmitted human pathogen. Its capsid protein contains three domains S, P1 and P2. The latter forms a homodimer protruding from the virus shell, making it the most exposed part. By combining biochemical and computational methods, we found the trypsin digestion sites to be highly conserved among the HEV strains. Furthermore, the constructs of the HEV capsid protein that contain an extended P2 domain were digested within the extensions leaving the P2 domain intact. The trypsinization seems to occur in three possible double cleavages at R451-R619, R460-R619 or R460-R631.The dimerization disrupts the trypsin action at three main sites in the P2 domain R542, K544 and K554. These sites are very exposed in the monomeric P2 domain constructs which makes the monomeric forms very susceptible to trypsin action. Therefore, we believe that dimerization is a structural feature that has been selected by the evolutionary forces to render the HEV capsid protein resistant to the host's proteases; an evolutionary feature that could be common to some other (if not all) orally-transmitted viruses.

摘要

经口传播的病毒已经进化出了抵抗宿主胃肠道环境极端条件的能力,尤其是抵抗其结构蛋白的蛋白水解作用。然而,这些病毒能够在这些恶劣条件下生存的机制仍不清楚。戊型肝炎病毒(HEV)是一种经口传播的人类病原体。其衣壳蛋白包含三个结构域 S、P1 和 P2。后者形成一个从病毒壳中突出的同源二聚体,使其成为最暴露的部分。通过结合生化和计算方法,我们发现 HEV 株之间的胰蛋白酶消化位点高度保守。此外,包含扩展 P2 结构域的 HEV 衣壳蛋白构建体在延伸部分被消化,而 P2 结构域保持完整。胰蛋白酶似乎可以在 R451-R619、R460-R619 或 R460-R631 三个可能的双切割位点发生。二聚化破坏了 P2 结构域中三个主要位点的胰蛋白酶作用,即 R542、K544 和 K554。这些位点在单体 P2 结构域构建体中非常暴露,这使得单体形式非常容易受到胰蛋白酶的作用。因此,我们认为二聚化是一种结构特征,它已经被进化力量选择,使 HEV 衣壳蛋白能够抵抗宿主的蛋白酶;这种进化特征可能在其他(如果不是全部)经口传播的病毒中是共同存在的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebc/5788867/a23e696d0c66/41598_2018_20137_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebc/5788867/efe8712e5b0a/41598_2018_20137_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebc/5788867/284e9f7e684a/41598_2018_20137_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebc/5788867/bb9e94bccc1d/41598_2018_20137_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebc/5788867/a23e696d0c66/41598_2018_20137_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebc/5788867/efe8712e5b0a/41598_2018_20137_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebc/5788867/284e9f7e684a/41598_2018_20137_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebc/5788867/bb9e94bccc1d/41598_2018_20137_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebc/5788867/a23e696d0c66/41598_2018_20137_Fig4_HTML.jpg

相似文献

1
Dimerization: a structural feature for the protection of hepatitis E virus capsid protein against trypsinization.二聚化:保护戊型肝炎病毒衣壳蛋白免受胰蛋白酶作用的结构特征。
Sci Rep. 2018 Jan 29;8(1):1738. doi: 10.1038/s41598-018-20137-2.
2
Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction.戊型肝炎病毒衣壳蛋白E2s结构域的二聚化对于病毒与宿主的相互作用至关重要。
PLoS Pathog. 2009 Aug;5(8):e1000537. doi: 10.1371/journal.ppat.1000537. Epub 2009 Aug 7.
3
[Interface domain of hepatitis E virus capsid protein homodimer].[戊型肝炎病毒衣壳蛋白同二聚体的界面结构域]
Sheng Wu Gong Cheng Xue Bao. 2004 Jan;20(1):90-8.
4
Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding.戊型肝炎病毒样颗粒的结构揭示了病毒组装和受体结合的机制。
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12992-7. doi: 10.1073/pnas.0904848106. Epub 2009 Jul 21.
5
Role of asparagine at position 562 in dimerization and immunogenicity of the hepatitis E virus capsid protein.戊型肝炎病毒衣壳蛋白562位天冬酰胺在二聚化和免疫原性中的作用。
Infect Genet Evol. 2016 Jan;37:99-107. doi: 10.1016/j.meegid.2015.11.006. Epub 2015 Nov 14.
6
Activities of Thrombin and Factor Xa Are Essential for Replication of Hepatitis E Virus and Are Possibly Implicated in ORF1 Polyprotein Processing.凝血酶和Xa因子的活性对于戊型肝炎病毒的复制至关重要,并且可能与ORF1多聚蛋白的加工有关。
J Virol. 2018 Feb 26;92(6). doi: 10.1128/JVI.01853-17. Print 2018 Mar 15.
7
Presence of a surface-exposed loop facilitates trypsinization of particles of Sinsiro virus, a genogroup II.3 norovirus.表面暴露环的存在有助于对基因组II.3型诺如病毒——辛西罗病毒颗粒进行胰蛋白酶消化。
J Virol. 2007 Feb;81(3):1119-28. doi: 10.1128/JVI.01909-06. Epub 2006 Nov 1.
8
Antigenic and Cryo-Electron Microscopy Structure Analysis of a Chimeric Sapovirus Capsid.嵌合萨波病毒衣壳的抗原性和冷冻电子显微镜结构分析
J Virol. 2015 Dec 23;90(5):2664-75. doi: 10.1128/JVI.02916-15.
9
Characterization of Two Novel Linear B-Cell Epitopes in the Capsid Protein of Avian Hepatitis E Virus (HEV) That Are Common to Avian, Swine, and Human HEVs.禽戊型肝炎病毒(HEV)衣壳蛋白中两个新型线性B细胞表位的鉴定,这些表位在禽、猪和人HEV中是共有的。
J Virol. 2015 May;89(10):5491-501. doi: 10.1128/JVI.00107-15. Epub 2015 Mar 4.
10
Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.戊型肝炎病毒生命周期和 ORF2 衣壳蛋白 3 种形式的鉴定。
Gastroenterology. 2018 Jan;154(1):211-223.e8. doi: 10.1053/j.gastro.2017.09.020. Epub 2017 Sep 25.

引用本文的文献

1
An experimental chimeric hepatitis E virus vaccine elicits both local and systemic immune responses.一种实验性嵌合戊型肝炎病毒疫苗可引发局部和全身免疫反应。
Front Microbiol. 2024 Dec 24;15:1512018. doi: 10.3389/fmicb.2024.1512018. eCollection 2024.
2
Inhibition of HEV Replication by FDA-Approved RdRp Inhibitors.美国食品药品监督管理局(FDA)批准的RNA依赖性RNA聚合酶(RdRp)抑制剂对戊型肝炎病毒(HEV)复制的抑制作用
ACS Omega. 2023 Oct 27;8(44):41570-41578. doi: 10.1021/acsomega.3c05637. eCollection 2023 Nov 7.
3
Discovery of Hepatitis E and Its Impact on Global Health: A Journey of 44 Years about an Incredible Human-Interest Story.

本文引用的文献

1
A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine.一项评估新型重组戊型肝炎疫苗安全性和耐受性的1期随机开放标签临床研究。
Vaccine. 2017 Sep 5;35(37):5073-5080. doi: 10.1016/j.vaccine.2017.05.072. Epub 2017 Aug 10.
2
Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection.口服幽门螺杆菌疫苗包封的耐酸HP55/聚乳酸-羟基乙酸共聚物纳米颗粒可促进免疫保护。
Eur J Pharm Biopharm. 2017 Feb;111:33-43. doi: 10.1016/j.ejpb.2016.11.007. Epub 2016 Nov 16.
3
Hepatitis E: prevention and treatment.
戊型肝炎的发现及其对全球健康的影响:一个长达 44 年的关于人类利益的不可思议的故事。
Viruses. 2023 Aug 15;15(8):1745. doi: 10.3390/v15081745.
4
The Capsid (ORF2) Protein of Hepatitis E Virus in Feces Is C-Terminally Truncated.粪便中戊型肝炎病毒的衣壳(ORF2)蛋白C端截短。
Pathogens. 2021 Dec 26;11(1):24. doi: 10.3390/pathogens11010024.
5
Galectin-1 Cooperates with Yersinia Outer Protein (Yop) P to Thwart Protective Immunity by Repressing Nitric Oxide Production.半乳糖凝集素-1 与耶尔森菌外蛋白(Yop)P 合作,通过抑制一氧化氮产生来破坏保护性免疫。
Biomolecules. 2021 Nov 4;11(11):1636. doi: 10.3390/biom11111636.
6
The Hepatitis E Virus Open Reading Frame 2 Protein: Beyond Viral Capsid.戊型肝炎病毒开放阅读框2蛋白:超越病毒衣壳
Front Microbiol. 2021 Oct 7;12:739124. doi: 10.3389/fmicb.2021.739124. eCollection 2021.
7
Design and development of a chimeric vaccine candidate against zoonotic hepatitis E and foot-and-mouth disease.设计和开发针对人畜共患戊型肝炎和口蹄疫的嵌合疫苗候选物。
Microb Cell Fact. 2020 Jul 11;19(1):137. doi: 10.1186/s12934-020-01394-1.
戊型肝炎:预防与治疗
Curr Opin Infect Dis. 2016 Oct;29(5):478-85. doi: 10.1097/QCO.0000000000000294.
4
Hepatitis E, the neglected one.戊型肝炎,被忽视的肝炎。
Liver Int. 2016 Jan;36 Suppl 1:130-4. doi: 10.1111/liv.13014.
5
Role of asparagine at position 562 in dimerization and immunogenicity of the hepatitis E virus capsid protein.戊型肝炎病毒衣壳蛋白562位天冬酰胺在二聚化和免疫原性中的作用。
Infect Genet Evol. 2016 Jan;37:99-107. doi: 10.1016/j.meegid.2015.11.006. Epub 2015 Nov 14.
6
Hepatitis E: an emerging global disease - from discovery towards control and cure.戊型肝炎:一种新兴的全球性疾病——从发现到控制与治愈
J Viral Hepat. 2016 Feb;23(2):68-79. doi: 10.1111/jvh.12445. Epub 2015 Sep 6.
7
Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.两种“老”抗生素——多粘菌素B和氯霉素对产NDM的多重耐药肺炎克雷伯菌的协同杀菌作用。
J Antimicrob Chemother. 2015 Sep;70(9):2589-97. doi: 10.1093/jac/dkv135. Epub 2015 May 28.
8
The Phyre2 web portal for protein modeling, prediction and analysis.用于蛋白质建模、预测和分析的Phyre2网络门户。
Nat Protoc. 2015 Jun;10(6):845-58. doi: 10.1038/nprot.2015.053. Epub 2015 May 7.
9
Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody.一种跨基因型抗体中和戊型肝炎病毒的结构基础
Cell Res. 2015 May;25(5):604-20. doi: 10.1038/cr.2015.34. Epub 2015 Mar 20.
10
Consensus proposals for classification of the family Hepeviridae.关于疱疹病毒科分类的共识建议。
J Gen Virol. 2014 Oct;95(Pt 10):2223-2232. doi: 10.1099/vir.0.068429-0. Epub 2014 Jul 2.